These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10172594)

  • 1. Transfer of DNA tests from research to routine laboratories: some lessons from the French experience in the case of Duchenne muscular dystrophy.
    Hirtzlin I
    Health Policy; 1996 Jan; 35(1):1-11. PubMed ID: 10172594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience and strategy for the molecular testing of Duchenne muscular dystrophy.
    Prior TW; Bridgeman SJ
    J Mol Diagn; 2005 Aug; 7(3):317-26. PubMed ID: 16049303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duchenne muscular dystrophy: systematic neonatal screening and earlier detection of carriers.
    Plauchu H; Dellamonica C; Cotte J; Robert JM
    J Genet Hum; 1980 Dec; 28(4):65-82. PubMed ID: 7205199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and new treatments in muscular dystrophies.
    Manzur AY; Muntoni F
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):706-14. PubMed ID: 19531685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of carriers for Duchenne muscular dystrophy. Quality control of creatine kinase assay.
    Plauchu H; Junien C; Maire I; Said R; Gozlan R; Lalouel JM
    Hum Genet; 1982; 61(3):205-9. PubMed ID: 7173863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The resource implications and service outcomes of genetic services in the context of DNA technology.
    Beech R; Rona RJ; Mandalia S
    Health Policy; 1994 Jan; 26(3):171-90. PubMed ID: 10133130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction.
    Greenberg CR; Jacobs HK; Halliday W; Wrogemann K
    Am J Med Genet; 1991 Apr; 39(1):68-75. PubMed ID: 1867267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-blind study of dystrophin staining in carriers of Duchenne muscular dystrophy.
    Bernier FP; Greenberg CR; Halliday WC; Wrogemann K
    Can J Neurol Sci; 1993 Feb; 20(1):44-7. PubMed ID: 8467428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genotypic diagnosis of Duchenne and Becker muscular dystrophies].
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Ann Biol Clin (Paris); 1999; 57(4):417-26. PubMed ID: 10432364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne muscular dystrophy in South Africa. Prevention by molecular techniques.
    Goldblatt J; Ballo R; Wallis G; Shapera J; Beighton P
    S Afr Med J; 1987 Dec; 72(12):835-7. PubMed ID: 3480586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of Duchenne and Becker muscular dystrophy.
    Abbs S
    Prenat Diagn; 1996 Dec; 16(13):1187-98. PubMed ID: 9061750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for molecular screening of newborns: simultaneous detection of Duchenne/Becker muscular dystrophies and cystic fibrosis.
    Prior TW; Highsmith WE; Friedman KJ; Perry TR; Scheuerbrandt G; Silverman LM
    Clin Chem; 1990 Oct; 36(10):1756-9. PubMed ID: 2208650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biology in diagnosis and detection of deletion in Duchenne muscular dystrophy].
    Graninger W; Wintersberger W; Meron G; Smolen J; Toifl K; Vormittag W
    Wien Klin Wochenschr; 1991; 103(7):207-9. PubMed ID: 2063586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-year follow-up of newborn screening for patients with muscular dystrophy.
    Chung J; Smith AL; Hughes SC; Niizawa G; Abdel-Hamid HZ; Naylor EW; Hughes T; Clemens PR
    Muscle Nerve; 2016 Apr; 53(4):570-8. PubMed ID: 26260293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the dystrophin gene in Southern French DMD or BMD families: from Southern blot to protein truncation test.
    Tuffery S; Chambert S; Bareil C; Sarda P; Coubes C; Echenne B; Demaille J; Claustres M
    Hum Genet; 1998 Mar; 102(3):334-42. PubMed ID: 9544849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of Duchenne muscular dystrophy: a three-year experience in a rapidly evolving field.
    Bakker E; Bonten EJ; Veenema H; den Dunnen JT; Grootscholten PM; van Ommen GJ; Pearson PL
    J Inherit Metab Dis; 1989; 12 Suppl 1():174-90. PubMed ID: 2509804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.
    Hoogerwaard EM; Bakker E; Ippel PF; Oosterwijk JC; Majoor-Krakauer DF; Leschot NJ; Van Essen AJ; Brunner HG; van der Wouw PA; Wilde AA; de Visser M
    Lancet; 1999 Jun; 353(9170):2116-9. PubMed ID: 10382696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
    Rodrigues M; Yokota T
    Methods Mol Biol; 2018; 1828():31-55. PubMed ID: 30171533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.